Analyst Ratings for Surgery Partners (SGRY) [Neutrals]
SGRY Rating Summary
SGRY Price Target Summary
- Highest: $50.00 (Benchmark)
- Lowest: $35.00 (Barclays)
- Average: $41.29
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$41.29 (+60.9%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 69%
Avg. $ Target:
$41.29 (+60.9%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2024 | Barclays | Andrew Mok | New Coverage | Equalweight (N/A) |
35.00 (N/A) |
30.50 (25.66) |
-15.87% | Details |
| 11/1/2021 | JPMorgan » Updated 12/13/2023 |
Lida Gill | New Coverage | Neutral (N/A) |
38.00 (42.00) |
40.89 (25.66) |
-37.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
